5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?-Reference-Cited by-同舟云学术

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?

Published:2021-01 Issue: Volume:Volume 13 Page:147-161
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Liu Zining^ORCID,Wang Yinkui,Shan Fei^ORCID,Ying Xiangji,Zhang Yan,Li Shuangxi,Jia Yongning,Li Ziyu^ORCID,Ji Jiafu^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference48 articles.

1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine

4. Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

5. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer;Frontiers in Oncology;2022-12-23

2. Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D2 Resection for Stage III Gastric Cancer;Journal of Gastric Cancer;2022

3. Optimal Duration of Adjuvant Chemotherapy for Gastric Cancer: Might Less Be More?;Journal of Gastric Cancer;2022

4. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy;World Journal of Gastrointestinal Oncology;2021-12-15

5. Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved;Frontiers in Oncology;2021-12-01